MARK GOLDSTEIN

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology ATLANTIS, FL NPI 1013952282

General Payments — all program years on this page

$4,366.82

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 51
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $624.09 across 11 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $624.0911

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
F. Hoffmann-La Roche AG $124.842
Lilly USA, LLC $119.271
Sumitomo Pharma America, Inc. $99.011
E.R. Squibb & Sons, L.L.C. $94.581
Biogen, Inc. $65.991
EISAI INC. $52.272
UCB SA $25.641
ABBVIE INC. $24.781
Novo Nordisk AS $17.711

By program year

Program yearAmountRecords
2018 $528.814
2019 $964.4213
2020 $20.541
2021 $154.972
2022 $1,774.4516
2023 $299.544
2024 $624.0911

Records — PY2024 (11)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097035578 Novo Nordisk Inc $17.71 07/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101669744 E.R. Squibb & Sons, L.L.C. $94.58 07/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103812756 ABBVIE INC. $24.78 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104873920 Biogen, Inc. $65.99 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110763505 Eisai Inc. $30.45 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110763507 Eisai Inc. $21.82 02/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113951097 UCB SA $25.64 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133062389 F. Hoffmann-La Roche AG $70.70 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133062393 F. Hoffmann-La Roche AG $54.14 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135113864 Lilly USA, LLC $119.27 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148857249 Sumitomo Pharma America, Inc. $99.01 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.